SOD1 and diabetic kidney disease: The nephroprotection of fucoidan nanoparticles appears to be related to the antioxidative stress that suppresses MDA and increases SOD and GPx expression and the anti-inflammatory effect that decreases IL-6 and TNF-α, which can further decrease BUN and creatinine levels in diabetic nephropathy.